remaining questions with multiple myeloma treatment
Published 6 years ago • 211 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
1:15
dr. kansagra on remaining questions with car t-cell therapy in multiple myeloma
-
1:02
should frontline myeloma treatment include a 3- or 4-drug regimen?
-
1:23
challenges to overcome in treating multiple myeloma
-
3:25
unmet needs and unanswered questions in multiple myeloma
-
9:05
targeted treatment options in multiple myeloma
-
55:48
hitting the bcma target in multiple myeloma
-
1:48
the impact of cd38-targeted therapy in multiple myeloma
-
7:13
treating relapsed/refractory multiple myeloma with car t-cell therapy
-
3:30
treating beyond progression in multiple myeloma
-
5:49
testing and therapy options for relapsed stage ii multiple myeloma
-
3:01
diagnosis of stage 2 multiple myeloma
-
1:25
what are the side effects of targeted therapies for multiple myeloma? | norton cancer institute
-
1:58
blood cancer research: targeted therapy in multiple myeloma
-
0:53
car t cells in the treatment landscape of multiple myeloma
-
48:06
the latest insights on immune therapies in myeloma | 2023 imf patient and family seminar
-
1:03
dr. zonder on induction therapy in newly diagnosed multiple myeloma
-
5:53
role of 4-drug regimens in treatment of multiple myeloma
-
56:40
immunotherapy 101 for multiple myeloma patients
-
1:56
why do many mm patients relapse after being treated with targeted therapy?